Overall employee rating

3.2
Based on 27 reviews
Rating distribution: 0 reviews rated 5 out of 5 stars. 0 reviews rated 4 out of 5 stars. 26 reviews rated 3 out of 5 stars. 1 reviews rated 2 out of 5 stars. 0 reviews rated 1 out of 5 stars.
5
4
3
2
1
Detail Ratings
Work life balance
3.0
Career Growth
3.0
Work flexibility
3.0
Job Security
4.0
Pay and benefits
4.0
Leadership
3.0
Company Culture
3.0
Disclaimer: Reviews on Jobstore are independently submitted by users; we do not guarantee the accuracy or truth of any individual submission. Read more
Regulatory Affairs Specialist
3.4
5 March 2026
Hybrid Work is Decent, But Can Be Stiff
Pros: The hybrid model (3 days onsite) for us in the pharmaceutical industry is better than full office. You get some work-from-home time, which helps avoid that brutal New Jersey commute. It's a solid setup if you like some office presence for collaboration.
Cons: The 'flexibility' often feels forced. Even for a Regulatory Affairs Specialist, those mandated onsite days are non-negotiable, even if you don't have meetings. It can be tough to juggle personal appointments when you're stuck to the office schedule. True WFH for more than 2 days a week is rare.
Advice to Management: Consider more true work_flexibility, especially for roles like Regulatory Affairs that often don't need constant in-person supervision. Trust your employees more with their schedules, especially after proving themselves during the pandemic.
Show more
Research Scientist
3.3
3 February 2026
Hybrid model works, but could be better
Pros: The hybrid model (3 days in office) is pretty standard for big pharma now, which is a decent compromise. For a Research Scientist, it helps with lab work but also gives some remote time. I appreciate the flexibility on which days you come in.
Cons: Sometimes it feels like they could offer more remote work, especially for non-lab focused tasks. The 'in-office' mandate can feel a bit rigid. It's tough when you're working on tight drug development deadlines and need to be fully focused.
Advice to Management: Consider reviewing the hybrid policy for specific R&D roles, especially those with less lab dependency. More flexible remote options could boost morale and productivity for many in the Cambridge, MA office.
Show more
Clinical Research Associate
3.4
8 December 2025
Hybrid Model Works, But Onsite is Still Heavy
Pros: I really liked the hybrid work option when it started. Being able to work from home a few days a week was great for my work-life balance. For many roles in the pharmaceutical industry, especially non-lab based ones, this is a solid perk.
Cons: The mandated onsite days felt a bit much, sometimes up to three days a week in the East Hanover office. It often felt like we were just doing remote work from the office anyway. It's not truly flexible if you're stuck to a rigid schedule.
Advice to Management: Re-evaluate the necessity of so many mandated onsite days. True work flexibility for research roles could improve employee morale and retention. Trust your teams more.
Show more

Latest jobs from Novartis

More jobs
Clinical Research Associate
3.3
4 December 2025
Hybrid model is fine, could be better
Pros: I like the hybrid model here; we get a few days working from home. It's helpful for balancing personal appointments. This setup is common in the pharmaceutical industry now.
Cons: There are mandated office days, usually three days a week in the East Hanover, NJ office. This limits true flexibility for a Clinical Research Associate. Sometimes I wish it was more flexible.
Advice to Management: Give teams more autonomy on WFH days rather than strict mandates. Trust your employees to get the work done, regardless of location.
Show more

See More Companies

Are you sure?

Once you confirm, please note that this action cannot be undone.